Zurich Insurance Group AG
Zurich Insurance Group AG (ZFSVF) Financial Performance & Income Statement Overview
Review Zurich Insurance Group AG (ZFSVF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Zurich Insurance Group AG (ZFSVF) Income Statement & Financial Overview
View the income breakdown for Zurich Insurance Group AG ZFSVF across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $17.67B | $17.67B | $16.69B | $16.69B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $17.67B | $17.67B | $16.69B | $16.69B |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $904.50M | $904.50M | $883.00M | $883.00M |
| Operating Expenses | $904.50M | $904.50M | $883.00M | $883.00M |
| Total Costs & Expenses | $904.50M | $904.50M | $883.00M | $883.00M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $0.00 | -$97.00M | $0.00 |
| EBITDA | $0.00 | $0.00 | $31.52B | $15.71B |
| EBITDA Ratio | $0.00 | $0.00 | $1.89 | $0.94 |
| Operating Income | $16.77B | $16.77B | $15.81B | $15.81B |
| Operating Income Ratio | $0.95 | $0.95 | $0.95 | $0.95 |
| Other Income/Expenses (Net) | -$14.78B | -$14.78B | -$13.56B | -$13.56B |
| Income Before Tax | $1.99B | $1.99B | $2.24B | $2.24B |
| Income Before Tax Ratio | $0.11 | $0.11 | $0.13 | $0.13 |
| Income Tax Expense | $498.50M | $498.50M | $632.00M | $632.00M |
| Net Income | $1.39B | $1.39B | $1.51B | $1.51B |
| Net Income Ratio | $0.08 | $0.08 | $0.09 | $0.09 |
| EPS | $9.75 | $9.75 | $10.41 | $10.41 |
| Diluted EPS | $9.66 | $9.66 | $10.41 | $10.41 |
| Weighted Avg Shares Outstanding | $144.26M | $144.26M | $145.34M | $145.34M |
| Weighted Avg Shares Outstanding (Diluted) | $144.26M | $144.26M | $145.34M | $145.34M |
The company's financials show resilient growth, with revenue advancing from $16.69B in Q1 2024 to $17.67B in Q4 2024. Gross profit remained healthy with margins at 100% in Q4 2024 compared to 100% in Q1 2024. Operating income hit $16.77B last quarter, sustaining a consistent 95% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $0.00. Net income rose to $1.39B, while earnings per share reached $9.75. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan